Solventum Corp. (SOLV)
89.08
+0.27
(+0.30%)
USD |
NYSE |
Nov 13, 16:00
89.56
+0.48
(+0.54%)
Pre-Market: 08:51
Solventum Shareholders Equity (Quarterly) : 4.805B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.805B |
| June 30, 2026 | 4.80B |
| March 31, 2026 | 4.969B |
| December 31, 2025 | 5.049B |
| September 30, 2025 | 4.986B |
| June 30, 2025 | 3.645B |
| Date | Value |
|---|---|
| March 31, 2025 | 3.262B |
| December 31, 2024 | 2.959B |
| September 30, 2024 | 3.192B |
| June 30, 2024 | 2.867B |
| March 31, 2024 | 3.851B |
| December 31, 2023 | 11.67B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Globus Medical, Inc. | 4.796B |
| Edwards Lifesciences Corp. | 10.86B |
| Intuitive Surgical, Inc. | 15.99B |
| Stryker Corp. | 23.46B |
| Inspire Medical Systems, Inc. | 826.95M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.16B |
| Total Liabilities (Quarterly) | 9.359B |
| Debt to Equity Ratio | 1.098 |
| Current Ratio | 1.033 |
| Net Debt Paydown Yield | 3.39% |